Browsing byAuthorMcKenzie, ANJ
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
2021-07 | Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. | Jacquelot, N; Seillet, C; Wang, M; Pizzolla, A; Liao, Y; Hediyeh-Zadeh, S; Grisaru-Tal, S; Louis, C; Huang, Q; Schreuder, J; Souza-Fonseca-Guimaraes, F; de Graaf, CA; Thia, K; Macdonald, S; Camilleri, M; Luong, K; Zhang, S; Chopin, M; Molden-Hauer, T; Nutt, SL; Umansky, V; Ciric, B; Groom, JR; Foster, PS; Hansbro, PM; McKenzie, ANJ; Gray, DHD; Behren, A; Cebon, J; Vivier, E; Wicks, IP; Trapani, JA; Munitz, A; Davis, MJ; Shi, W; Neeson, PJ; Belz, GT |
2019-01-01 | Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury | Cameron, GJM; Cautivo, KM; Loering, S; Jiang, SH; Deshpande, AV; Foster, PS; McKenzie, ANJ; Molofsky, AB; Hansbro, PM; Starkey, MR |
2009-06-01 | Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype | Fukuyama, S; Nakano, T; Matsumoto, T; Oliver, BGG; Burgess, JK; Moriwaki, A; Tanaka, K; Kubo, M; Hoshino, T; Tanaka, H; McKenzie, ANJ; Matsumoto, K; Aizawa, H; Nakanishi, Y; Yoshimura, A; Black, JL; Inoue, H |
2019-01-01 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease | Donovan, C; Starkey, MR; Kim, RY; Rana, BMJ; Barlow, JL; Jones, B; Haw, TJ; Mono Nair, P; Budden, K; Cameron, GJM; Horvat, JC; Wark, PA; Foster, PS; McKenzie, ANJ; Hansbro, PM |